Evidence map›Paper›PMID 30799147›Full record

ArticleMolecular cell2019

System-wide Profiling of RNA-Binding Proteins Uncovers Key Regulators of Virus Infection.

Manuel Garcia-Moreno, Marko Noerenberg, Shuai Ni, Aino I Järvelin, Esther González-Almela, Caroline E Lenz, Marcel Bach-Pages, Victoria Cox, Rosario Avolio, Thomas Davis and 13 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular cell, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 120 papers.

0numbers the graph read from it
0cells of the map it votes in
120citing papers in PubMed
9.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

120 citing papers in PubMed, 205 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

60 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 6 institutions in 7 countries.

Manuel Garcia-MorenoDepartment of Biochemistry, University of Oxford, OX1 3QU Oxford, UK.
Marko NoerenbergDepartment of Biochemistry, University of Oxford, OX1 3QU Oxford, UK.
Shuai NiGerman Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
Aino I JärvelinDepartment of Biochemistry, University of Oxford, OX1 3QU Oxford, UK.
Esther González-AlmelaCentro de Biologia Molecular "Severo Ochoa," Universidad Autonoma de Madrid, 28049 Madrid, Spain.
Caroline E LenzDepartment of Biochemistry, University of Oxford, OX1 3QU Oxford, UK.
Marcel Bach-PagesDepartment of Biochemistry, University of Oxford, OX1 3QU Oxford, UK.
Victoria CoxDepartment of Biochemistry, University of Oxford, OX1 3QU Oxford, UK.
Rosario AvolioDepartment of Biochemistry, University of Oxford, OX1 3QU Oxford, UK; Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Thomas DavisDepartment of Biochemistry, University of Oxford, OX1 3QU Oxford, UK.
Svenja HesterDepartment of Biochemistry, University of Oxford, OX1 3QU Oxford, UK.
Thibault J M SohierUniversité de Lyon, ENSL, UCBL, CNRS, INSERM, LBMC, 46 Allée d'Italie, 69007 Lyon, France.
Bingnan LiSciLifeLab, Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, 17165 Solna, Sweden.
Gregory HeikelWellcome Centre for Cell Biology, University of Edinburgh, Michael Swann Building, Edinburgh EH9 3BF, UK; Division of Infection and Pathway Medicine, University of Edinburgh, The Chancellor's Building, 49 Little France Crescent, Edinburgh EH16 4SB, UK.
Gracjan MichlewskiWellcome Centre for Cell Biology, University of Edinburgh, Michael Swann Building, Edinburgh EH9 3BF, UK; Division of Infection and Pathway Medicine, University of Edinburgh, The Chancellor's Building, 49 Little France Crescent, Edinburgh EH16 4SB, UK; Zhejiang University-University of Edinburgh Institute, Zhejiang University, 718 East Haizhou Road, Haining, Zhejiang 314400, People's Republic of China.
Miguel A SanzCentro de Biologia Molecular "Severo Ochoa," Universidad Autonoma de Madrid, 28049 Madrid, Spain.
Luis CarrascoCentro de Biologia Molecular "Severo Ochoa," Universidad Autonoma de Madrid, 28049 Madrid, Spain.
Emiliano P RicciUniversité de Lyon, ENSL, UCBL, CNRS, INSERM, LBMC, 46 Allée d'Italie, 69007 Lyon, France.
Vicent PelechanoSciLifeLab, Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, 17165 Solna, Sweden.
Ilan DavisDepartment of Biochemistry, University of Oxford, OX1 3QU Oxford, UK.
Bernd FischerGerman Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Shabaz MohammedDepartment of Biochemistry, University of Oxford, OX1 3QU Oxford, UK; Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford OX1 3TA, UK.
Alfredo CastelloDepartment of Biochemistry, University of Oxford, OX1 3QU Oxford, UK. Electronic address: alfredo.castellopalomares@bioch.ox.ac.uk.
University of Oxford · GBCentro de Biología Molecular Severo Ochoa · ESGerman Cancer Research Center · DEScience for Life Laboratory · SEUniversité Claude Bernard Lyon 1 · FRWellcome Centre for Cell Biology · GB

Funding

Medical Research Council MC_UU_12014/10Medical Research Council MR/L019434/1Medical Research Council MR/R021562/1Wellcome Trust 092076Wellcome Trust 209412/Z/17/Z
6 · The paper itself

Abstract

The compendium of RNA-binding proteins (RBPs) has been greatly expanded by the development of RNA-interactome capture (RIC). However, it remained unknown if the complement of RBPs changes in response to environmental perturbations and whether these rearrangements are important. To answer these questions, we developed "comparative RIC" and applied it to cells challenged with an RNA virus called sindbis (SINV). Over 200 RBPs display differential interaction with RNA upon SINV infection. These alterations are mainly driven by the loss of cellular mRNAs and the emergence of viral RNA. RBPs stimulated by the infection redistribute to viral replication factories and regulate the capacity of the virus to infect. For example, ablation of XRN1 causes cells to be refractory to SINV, while GEMIN5 moonlights as a regulator of SINV gene expression. In summary, RNA availability controls RBP localization and function in SINV-infected cells.

Indexed as

Transcriptome5' Untranslated RegionsBinding SitesEpithelial CellsExoribonucleasesFemaleGene Expression ProfilingGene Expression Regulation, ViralHEK293 CellsHeLa CellsHost-Pathogen InteractionsHumansMicrotubule-Associated ProteinsProtein BindingRibonucleoproteins, Small NuclearRNA-Binding Proteins5' Untranslated RegionsExoribonucleasesGEMIN5 protein, humanMicrotubule-Associated ProteinsRibonucleoproteins, Small NuclearRNA-Binding ProteinsRNA, ViralSMN Complex ProteinsXRN1 protein, humanalphavirusGEMIN5host-virus interactionprotein-RNA interactionRNA-binding proteinRNA-interactome captureSindbisTRIM25virus infectionXRN1

Identifiers

PMID30799147
PMCPMC6458987
OpenAlexW2915914054

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.